Pain and the immune system: Friend or foe?;Schmerz und immunsystem: Freund oder feind?

Anaesthesist

Volumn 51, Issue 5, 2002, Pages 351-358

  Rittner, H L ^a   Brack, A ^a   Stein, C ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Bradykinin; Cytokines; Inflammatory pain; Opioid peptides; Opioid receptors; Peripheral analgesia; Prostaglandins

Indexed keywords

BRADYKININ; CYTOKINE; ENDORPHIN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 6; NERVE GROWTH FACTOR; OPIATE PEPTIDE; PROSTAGLANDIN; TUMOR NECROSIS FACTOR;

ANALGESIA; CYTOKINE RELEASE; HUMAN; HYPERALGESIA; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; INFLAMMATION; NOCICEPTION; PAIN; PATHOPHYSIOLOGY; REVIEW; SENSORY NERVE CELL; TISSUE INJURY; WOUND HEALING;

HUMANS; IMMUNE SYSTEM; INFLAMMATION MEDIATORS; NOCICEPTORS; PAIN; RECEPTORS, OPIOID;

EID: 0036277702     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00101-002-0306-9     Document Type: Review

References (62)

1. Characterization of potassium currents in adult rat sensory neurons and modulation by opioids and cyclic AMP
2. Perineurial defect and peripheral opioid analgesia in inflammation
3. Proopiomelanocortin and the immune-neuroendocrine connection
4. Pain in ambulatory AIDS patients. I: Pain characteristics and medical correlates
5. Immune cell-derived beta-endorphin. Production, release, and control of inflammatory pain in rats
6. Methionine-enkephalin-and Dynorphin A-release from immune cells and control of inflammatory pain
7. Kinins in pain and inflammation
8. Somatostatin receptors on peripheral primary afferent terminals: Inhibition of sensitized nociceptors
9. Receptor localization in the mammalian dorsal horn and primary afferent neurons
10. Peripheral hyperalgesic cytokines
11. The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia
12. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-4
13. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-1 receptor antagonist
14. Increased content and transport of substance P and calcitonin gene-related peptide in sensory nerves innervating inflamed tissue: Evidence for a regulatory function of nerve growth factor in vivo
15. Expression of functional trk tyrosine kinase receptors after T cell activation
16. Neurotrophins and their receptors - Current concepts and implications for neurologic disease
17. Interleukin-1 beta as a potent hyperalgesic agent antagonized by a tripeptide analogue
18. Antinociceptive effect of the calcium-binding protein MRP-14 and the role played by neutrophils on the control of inflammatory pain
19. Tetrodotoxin-resistant Na+ currents and inflammatory hyperalgesia
20. Hyperalgesic agents increase a tetrodotoxin-resistant Na+ current in nociceptors
21. Inflammation of the rat paw enhances axonal transport of opioid receptors in the sciatic nerve and increases their density in the inflamed tissue
22. Pain syndromes and etiologies in ambulatory AIDS patients
23. Opioid peptide processing and receptor selectivity
24. Opioid inhibition of lh via adenylyl cyclase
25. Expression of mu-, delta-, and kappa-opioid receptor-like immunoreactivities in rat dorsal root ganglia after carrageenan-induced inflammation
26. Pain management for the AIDS patient
27. Mast cells synthesize, store, and release nerve growth factor
28. The role of the polymorphonuclear leukocyte in hyperalgesia
29. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-13
30. Pro-opiomelanocortin gene expression and protein processing in rat mononuclear leukocytes
31. Pain control in inflammation governed by selectins
32. Role of IL-1 beta and TNF-alpha in the regulation of NGF in experimentally induced arthritis in mice
33. Mu- and kappa-opioid receptors selectively reduce the same transient components of high-threshold calcium current in rat dorsal root ganglion sensory neurons
34. Co-expression of beta-endorphin with adhesion molecules in a model of inflammatory pain
35. Beta-Endorphin-containing memory-cells and mu-opioid receptors undergo transport to peripheral inflamed tissue
36. Hyperalgesia due to nerve injury: Role of neutrophils
37. Hypoalgesia and altered inflammatory responses in mice lacking kinin B1 receptors
38. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-10
39. Gene expression and localization of opioid peptides in immune cells of inflamed tissue: Functional role in antinociception
40. Corticotropin-releasing factor receptor 1 in mouse spleen: Expression after immune stimulation and identification of receptor-bearing cells
41. Involvement of resident macrophages and mast cells in the writhing nociceptive response induced by zymosan and acetic acid in mice
42. Opioid peptide-expressing leukocytes: Identification, recruitment, and simultaneously increasing inhibition of inflammatory pain
43. Opiates inhibit the discharges of fine afferent units from inflamed knee joint of the cat
44. Interleukin 1 beta and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue
45. Expression of corticotropin-releasing factor in inflamed tissue is required for intrinsic peripheral opioid analgesia
46. Corticotropin-releasing factor in antinociception and inflammation
47. Localization of kappa-opioid receptor mRNA in neuronal subpopulations of rat sensory ganglia and spinal cord
48. Modification of G protein-coupled functions by low-pH pretreatment of membranes from NG108-15 cells: Increase in opioid agonist efficacy by decreased inactivation of G proteins
49. Activation of ATP-sensitive K(+) channels: Mechanism of peripheral antinociceptive action of the nitric oxide donor, sodium nitroprusside
50. Intrinsic mechanisms of antinociception in inflammation: Local opioid receptors and beta-endorphin
51. Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation
52. Local analgesic effect of endogenous opioid peptides
53. Effects of intracolonic opioid receptor agonists on polymodal pelvic nerve afferent fibers in the rat
54. Characterization of the arachidonic acid metabolites mediating bradykinin and noradrenaline hyperalgesia
55. Effects of cyclooxygenase products of arachidonic acid metabolism on cutaneous nociceptive threshold in the rat
56. Further confirmation of the role of adenyl cyclase and of cAMP-dependent protein kinase in primary afferent hyperalgesia
57. Proenkephalin system in human polymorphonuclear cells. Production and release of a novel 1.0-kD peptide derived from synenkephalin
58. Dynorphin A-mediated reduction in multiple calcium currents involves a G(o) alpha-subtype G protein in rat primary afferent neurons
59. The acute abdomen in individuals with AIDS
60. Substance P release from knee joint afferent terminals: Modulation by opioids
61. A potent and selective endogenous agonist for the mu-opiate receptor
62. Effects of neurotoxins and hindpaw inflammation on opioid receptor immunoreactivities in dorsal root ganglia